Table 2.

Genotype–phenotype concordance of sraX analysis for selected E. faecalis and E. faecium strains.

		Phenotype: resistant (R)		Phenotype: susceptible (S)		Concordance )(%)
Drug	Species	Genotype: R	Genotype: S	Genotype: R	Genotype: S
GEN	E. faecium	12	1	0	87	99
	E. faecalis	37	1	4	55	95
KAN	E. faecium	18	4	1	77	95
	E. faecalis	47	1	1	48	98
ERY	E. faecium	25	7	3	65	90
	E. faecalis	53	1	2	41	97
TYL	E. faecium	26	2	2	70	96
	E. faecalis	54	1	1	41	98
CHL	E. faecium	2	0	0	98	100
	E. faecalis	20	0	2	75	98
TET	E. faecium	64	0	5	31	95
	E. faecalis	68	0	3	25	97
QDA	E. faecium	22	8	4	66	88
CIP	E. faecalis	1	0	0	96	100
VAN	E. faecium	0	0	0	100	100
	E. faecalis	0	0	0	97	100
LZD	E. faecium	0	0	0	100	100
	E. faecalis	0	0	0	97	100
Total		449	26	28	1269	97

GEN, gentamicin; KAN, kanamycin; ERY, erythromycin; TYL, tylosin; CHL, chloramphenicol; TET, tetracycline; QDA, quinupristin-dalfopristin; CIP, ciprofloxacin; VAN, vancomycin; LZD, linezolid.

Bold character indicates the verified global average concordance rate.